Minute Insight: Strados Earns FDA 510(k) To Let Patients Use RESP Sensor At Home
Executive Summary
The FDA cleared Strados’ RESP sensor to be incorporated into at-home remote monitoring of patients with pulmonary disease in addition to in-hospital monitoring. Strados expects the in-home indication will help physicians better understand their patients’ respiratory health “journey.”